NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
14.54
-0.74 (-4.84%)
At close: Feb 11, 2026, 4:00 PM EST
14.56
+0.02 (0.14%)
After-hours: Feb 11, 2026, 4:32 PM EST

NeuroPace Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
48533427137245-
Market Cap Growth
14.10%23.25%630.30%-84.86%--
Enterprise Value
49635128120171-
Last Close Price
14.5611.1910.311.4910.08-
PS Ratio
4.894.184.140.825.42-
PB Ratio
26.1741.6813.121.073.33-
P/TBV Ratio
26.1941.6813.121.073.33-
EV/Sales Ratio
5.234.394.300.443.79-
Debt / Equity Ratio
3.849.153.512.010.68-8.75
Net Debt / Equity Ratio
0.602.570.29-0.22-0.89-2.45
Net Debt / EBITDA Ratio
-0.62-0.96-0.220.192.80-1.16
Net Debt / FCF Ratio
-0.67-1.13-0.300.202.63-0.68
Asset Turnover
0.930.790.590.370.481.07
Inventory Turnover
1.461.691.651.491.601.47
Quick Ratio
3.824.334.857.7313.194.84
Current Ratio
4.865.375.718.9014.285.69
Return on Equity (ROE)
-169.27%-189.35%-118.91%-86.96%-106.96%-
Return on Assets (ROA)
-11.19%-13.39%-15.32%-20.59%-15.66%-21.17%
Return on Capital Employed (ROCE)
-20.80%-27.30%-29.70%-39.60%-19.10%-28.20%
Earnings Yield
-4.95%-8.13%-12.16%-126.89%-14.72%-
FCF Yield
-3.42%-5.47%-7.33%-100.99%-10.18%-
Buyback Yield / Dilution
-12.36%-12.67%-5.11%-48.08%-8038.86%61.14%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q